Jill Margo of the Australian Financial Review (aka the Wall Street Journal of Australia) wrote a column today headlined “Drug for Male Balding Linked to Sexual Problems in Small Numbers of Men.”
In it, she says:
“The United States’ National Institutes of Health has added PFS to its Genetic and Rare Diseases Information Centre. This comes at a time when a study in the Journal of the American Medical Association showed that of the 34 clinical trials conducted on finasteride, none adequately reported on sexual side-effects. Another new study in Hormone Molecular Biology and Clinical Investigation showed the drug increased the severity of erectile dysfunction and decreased testosterone levels in men with benignly enlarged prostates.”
The full story here:
afr.com/lifestyle/health/men … 623-ghudwx
Please click on it and share the link as widely as possible.